Johnson & Johnson exec Dr Sarah Siggins has signed on for ASX-listed Algorae Pharmaceuticals’ hunt to create drug combinations recommended by AI to tackle hard to beat diseases. Johnson & Johnson exec Dr Sarah Siggins has signed on for ASX-listed Algorae Pharmaceuticals’ hunt to create drug combinations recommended by AI to tackle hard to beat diseases. Business / Companies Sydney Morning Herald – Latest News
Johnson & Johnson exec signs on for Algorae AI drug development
